News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Winston Laboratories, Inc. Announces Licensing Agreement With Sanofi-Aventis (Canada). in Canada


11/7/2008 11:13:36 AM

VERNON HILLS, Ill.--(BUSINESS WIRE)--Winston Laboratories, Inc., a wholly owned subsidiary of Getting Ready Corporation (OTC: GTRY.OB), announced that on October 30, 2008 it entered into a licensing agreement with sanofi-aventis Canada Inc. for the Canadian rights to Winston’s proprietary transient receptor potential vanilloid (TRPV-1) modulator in formulations for topical application.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES